1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 01 JUNE 2015

Cancer Drug News 01 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Biologics Focus To Continue Driving In-House Biomanufacturing Investment
Industry Brief - Imbruvica Gains CHMP Positive Opinion In WM
Industry Brief - Masitinib Phase II Trial In r/r PTCL Accelerates Into Phase III
Industry Brief - Sophiris Enrols First Patients In Phase IIa PoC Trial Of PRX302
Industry Brief - Innocrin Begins VT-464 Phase II CRPCA Study
Industry Brief - Enzalutamide Phase II Trial Meets Primary Endpoint In Metastatic/Non-Metastatic PCA
Industry Brief - FDA Grants ODD To Cerulean's CRLX101 For OC
Industry Trend Analysis - T-VEC Set To Become First Western Viral Immunotherapy
Industry Brief - FDA Accepts sBLA For Opdivo+Yervoy In Untreated Advanced Melanoma
Industry Brief - EC Grants Approval For Eisai's Lenvima
Industry Brief - Regeneus To Start Personalised Human Cancer Vaccine Trial
Industry Trend Analysis - Juno Creating CAR-T Powerhouse
Industry Brief - Eureka/BI Collaborate To Develop Abs In Oncology
Industry Trend Analysis - Keytruda Companion Diagnostic Will Not Keep Roche At Bay
Industry Brief - AstraZeneca/Lilly Enter Immuno-Oncology Clinical Trial Collaboration
Industry Brief - Ono Seeks Japanese Additional Approval For Proemend In CINV
Industry Brief - Aloxi Gains EU Approval For CINV Prevention In Infants
Industry Brief - AbbVie Completes Pharmacyclics Acquisition
Industry Brief - Baxter Ventures/Mayo Clinic/VPD Form Vitesse Biologics
Industry Trend Analysis - Transposagen Spin-Out Prime Acquisition Target

Table Of Contents

Cancer Drug News 01 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.